Saquinavir/r (SQV/r) BID versus Lopinavir/r (LPV/r) BID, Plus Emtricitabine/Tenofovir (FTC/TDF) QD as Initial Therapy in HIV-1-infected Patients: The Gemini Study
University of Toronto, Canada
Disclosure : Served as a consultant and on a speakers bureau for Roche.
[More]
[Less]
18 slide(s) – 00:14:36 – English – 2007-10-25
|